tradingkey.logo

Abbott on track for best day in 2 years after reaffirming forecast amid tariff risks

ReutersApr 16, 2025 4:21 PM

Shares of medical device maker Abbott ABT.N rise 5.4% to $133.05

*ABT is the top performer on the S&P 500 .SPX index on Wednesday

Stock has its best day since April 2023, if gains hold

ABT, in a conference call, says it doesn't expect any tariff impact in Q2

Impact of tariffs is projected to be a few hundred million dollars in 2025 - company

ABT reaffirms its annual profit per share forecast of between $5.05 and $5.25, but beats Q1 earnings estimate

Company says two new manufacturing and R&D investments in Illinois and Texas, totaling $500 million, are projected to go live by the end of 2025

Up to last close, stock up 11.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI